Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19: The Experience From Iran Publisher Pubmed



Daneshpazhooh M1, 2 ; Mahmoudi H1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Clinics in Dermatology Published:2021


Abstract

The first cases of coronavirus disease 2019 (COVID-19) in Iran were detected on February 19, 2020. Soon the entire country was hit with the virus. Although dermatologists were not immediately the frontline health care workers, all aspects of their practice were drastically affected. Adapting to this unprecedented crisis required urgent appropriate responses. With preventive measures and conserving health care resources being the most essential priorities, dermatologists, as an integral part of the health system, needed to adapt their practices according to the latest guidelines. The spectrum of the challenges encompassed education, teledermatology, lasers, and other dermatologic procedures, as well as management of patients who were immunosuppressed or developed drug reactions and, most importantly, the newly revealed cutaneous signs of COVID-19. These challenges have paved the way for new horizons in dermatology. © 2020 Elsevier Inc.
Related Docs
View other Related Docs
1. Cutaneous Manifestations and Considerations in Covid-19 Pandemic: A Systematic Review, Dermatologic Therapy (2020)
2. Dermatological Manifestations Associated With Covid-19: A Comprehensive Review of the Current Knowledge, Journal of Medical Virology (2021)
3. The Efficacy of Rituximab in Patients With Mucous Membrane Pemphigoid, Journal of Dermatological Treatment (2022)
4. A Systematic Review on Efficacy, Safety, and Treatment-Durability of Low-Dose Rituximab for the Treatment of Pemphigus: Special Focus on Covid-19 Pandemic Concerns, Immunopharmacology and Immunotoxicology (2021)
5. A Comprehensive Review on Covid-19 Infection and Comorbidities of Various Organs, Acta Medica Iranica (2021)
6. Rituximab in Practice: Clinical Evaluation of Patients With Pemphigus After Rituximab Administration, Dermatologic Therapy (2021)
7. Cutaneous Manifestation of Covid-19: What Have We Learned an Year Into the Pandemic?; [[Articulo Traducido] Manifestaciones Cutaneas De La Covid-19: ¿Que Hemos Aprendido Tras Un Ano De Pandemia?], Actas Dermo-Sifiliograficas (2022)
8. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
Experts (# of related papers)
View all Related Experts
Maryam Daneshpajooh (33)
Hamid Reza Mahmoodi (27)
Other Related Docs
9. Applicability of Glucocorticoid Toxicity Index in Pemphigus: Comparison Between Two Groups of Rituximab-Treated and Rituximab-Naive Patients, Dermatologic Therapy (2022)
10. Cutaneous Manifestation of Covid-19: What Have We Learned an Year Into the Pandemic?; [Manifestaciones Cutaneas De La Covid-19: ¿Que Hemos Aprendido Tras Un Ano De Pandemia?], Actas Dermo-Sifiliograficas (2021)
11. Adverse Outcome and Severity of Covid-19 in Patients With Autoimmune Bullous Diseases: A Historical Cohort Study, Dermatologic Therapy (2022)
12. Rituximab in Childhood and Juvenile Autoimmune Bullous Diseases As First-Line and Second-Line Treatment: A Case Series of 13 Patients, Journal of Dermatological Treatment (2020)
13. Pustular Psoriasis Flare-Up in a Patient With Covid-19, Journal of Cosmetic Dermatology (2021)
14. Physical Problems of Prolonged Use of Personal Protective Equipment During the Covid-19 Pandemic: A Scoping Review, Nursing Forum (2022)
15. Dermatology Department: What We Could Do Amidst the Pandemic of Covid-19?, Journal of Dermatological Treatment (2022)
16. Iranian Guideline for Rituximab Therapy in Pemphigus Patients, Dermatologic Therapy (2019)
17. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?, Frontiers in Medicine (2022)
18. Treatment of Pemphigus Patients in the Covid-19 Era: A Specific Focus on Rituximab, Dermatologic Therapy (2020)
19. Cutaneous Manifestations Related to the Covid-19 Pandemic: A Review Article, Cutaneous and Ocular Toxicology (2021)
20. Intralesional Injection of Biosimilar Rituximab in Recalcitrant Mucocutaneous Lesions of Patients With Pemphigus Vulgaris: A Pilot Study, Dermatologic Therapy (2020)
21. A Systematic Review on Mucocutaneous Manifestations of Covid-19 in Children, Iranian Journal of Dermatology (2022)
22. Unmasking Pustular Psoriasis Subsequent to Covid-19, Journal of Pakistan Association of Dermatologists (2021)
23. Pemphigus Disease and Area Index: Unmet Needs in the Real-World Management of Pemphigus, Oral Diseases (2023)
24. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Factors Associated With the Healing Time of Pemphigus Vulgaris Oral Lesions: A Prospective Study, Oral Diseases (2023)
26. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
27. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
28. Rituximab Monotherapy in Mild Pemphigus, Journal of Dermatological Treatment (2022)
29. A Systematic Review on Efficacy, Safety and Treatment Durability of Intravenous Immunoglobulin in Autoimmune Bullous Dermatoses: Special Focus on Indication and Combination Therapy, Experimental Dermatology (2023)
30. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
31. Single-Nucleotide Polymorphisms Associated With Pemphigus Vulgaris: Potent Markers for Better Treatment and Personalized Medicine, International Journal of Immunogenetics (2020)
32. Short-Term Clinical and Serological Follow-Up With Conventional and Conformational Anti-Desmoglein Antibodies in Treatment-Naive and Previously Treated Patients With Pemphigus Vulgaris After Receiving Rituximab, International Journal of Women's Dermatology (2019)
33. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
34. Chilblain or Perniosis-Like Skin Lesions in Children During the Covid-19 Pandemic: A Systematic Review of Articles, Dermatologic Therapy (2022)
35. Histopathologic Changes and Cellular Events of Organs Systems in Covid-19, Journal of Cellular and Molecular Anesthesia (2021)
36. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
37. The Covid-19 Pandemic and Its Impact on Esthetic Dermatology, Journal of Cosmetic Dermatology (2022)
38. Cosmetic Surgeries Amidst Pandemic Area of Covid-19: Suggested Protocol, Journal of Dermatological Treatment (2020)
39. Frequency of Skin Lesions in Healthcare Workers During the Covid-19 Pandemic: An Update From Iran, Iranian Journal of Dermatology (2023)
40. Paradoxical Reaction to Rituximab in Patients With Pemphigus: A Report of 10 Cases, Immunopharmacology and Immunotoxicology (2020)
41. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19, Allergy# Asthma and Clinical Immunology (2021)
42. Covid-19 Infection Risk in Patients on Immunosuppressive/Immunomodulator Therapy: A Single Center Study, Dermatologic Therapy (2021)
43. Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris, Journal of Wound Care (2020)
44. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
45. How Covid-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment, Advances in Experimental Medicine and Biology (2021)
46. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
47. Efficacy and Safety of Biosimilar Rituximab in Patients With Pemphigus Vulgaris: A Prospective Observational Study, Journal of Dermatological Treatment (2021)
48. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
49. Extrapulmonary Manifestations of Covid-19: Radiologic and Clinical Overview, Clinical Imaging (2020)
50. Pemphigus Patients With Initial Negative Levels of Anti-Desmoglein: A Subtype With Different Profile?, Dermatologic Therapy (2022)